Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05918263

Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a 16-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among Black men with prostate cancer undergoing active surveillance. The name of the study intervention involved in this study is: Aerobic high-intensity interval training (HIIT) (training exercise intervention)

Detailed description

This research study is a randomized controlled study for a home-based, virtually supervised, aerobic exercise intervention for Black men with prostate cancer undergoing active surveillance. There is evidence that exercise may suppress cancer progression, but the evidence is preliminary and Black men with prostate cancer has been highly underrepresented in exercise clinical research despite their higher risk of cancer progression compared to White counterparts. Participants will be randomized into one of two treatment groups: Group A: Aerobic high-intensity interval training (HIIT) versus Group B: Usual Care. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, study treatment visits, survey questionnaires, blood tests, and follow-up visits. Participation in this research study is expected to last about 18 weeks. It is expected that about 68 people will take part in this research study. The Prostate Cancer Foundation is providing funding for this research study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh-Intensity Interval Training Exercise ProgramHome-based, virtually supervised, aerobic exercise program of 48 sessions accessible via internet-enabled tablet (provided to participant if needed). Participants will be supplied with stationary bike, heart rate monitor, and blood pressure monitor.

Timeline

Start date
2024-01-01
Primary completion
2026-03-31
Completion
2027-03-31
First posted
2023-06-26
Last updated
2026-03-12

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05918263. Inclusion in this directory is not an endorsement.